The Institute for Palliative Medicine at San Diego Hospice

Research Studies

Open Studies

04-014 ED “Evaluation of a Palliative Medicine Curriculum in 9 Different Physician Residency Programs”. PI: Charles von Gunten, MD. Sponsor: SDHIPM.
04-017 PS “Evaluation of Bereavement Counseling Curriculum for One-Year Internship”. PI: Noreen Carrington, LMFT. Sponsor: SDHIPM.
05-007 SD “Statewide Initiative to Disseminate an End-of-Life Curriculum”. PI: Charles von Gunten, MD. Sponsor: SDHIPM.
07-003 PS Cognitive Impairment and Decision Making Capacity in Hospice/Palliative Care Patients. PI: Scott Irwin, MD. Sponsor: SDHIPM.
07-005 SD Interdisciplinary Faculty Development Program. PI: Annette Vollrath, MD. Sponsor: SDHIPM.
07-006 SD Behaviors at the End of Life- Pilot Study.  PI: Charlene Paige, LVN. Sponsor: SDHIPM.
07-009 ED Long Term Care (LTC) Education Project. PI: Frank Ferris, MD. Sponsor: Archstone Foundation.
07-010 ED The Shared Care Model at San Diego Hospice & Palliative Care: Is there increased job satisfaction with the Shared Care Model as compared with the Tradition Model of hospice care? PI: Carolyn Stevenson, RN. Sponsor: SDHIPM.
07-011 PS The RapID-K Study PI: Scott Irwin, MD. Sponsor: SDHIPM.
08-001 ED A Retrospective Assessment of The Effectiveness of International Education Programs Using Standardized Competence and Knowledge Evaluations. PI: Frank Ferris, MD. Sponsor: SDHIPM.
08-003 MR Estimation of Opioid Usage in Hospice Patients at SDHP&C. PI: Frank Ferris, MD. Sponsor: SDHIPM.
08-004 ED Ukraine Introductory Education Intervention 2008. PI: Frank Ferris, MD. Sponsor: SDHIPM.
08-005 ED Saudi Arabia Education Intervention 2008. PI: Frank Ferris, MD. Sponsor: SDHIPM.
08-007 BR The Effects of Grief Counseling on Stress-Related Growth, Coping, and Purpose in Life in a Sample of Bereaved Adults PI: Christine Kennedy, MA, M.Div., PhD(c), LCPC. Sponsor: Hospice of The Chesapeake.
08-008 ED Developing a Spanish Language Version of the GO Wish Card Game. PI: Elizabeth Menkin, MD. Sponsor: SDHIPM.
08-009 MI A Randomized, Double-Blind, Placebo-Controlled Study of a Fixed Dose of The Subcutaneous Methylnaltrexone in Adults With Advanced Illness and Opioid-Induced Constipation: Efficacy, Safety, and Additional Health Outcomes PI: Charles von Gunten, MD. Sponsor: Wyeth Pharmaceuticals.
08-010 MI Open-Label Extension Study to Assess The Safety of a Fixed Dose of Subcutaneous Methylnaltrexone in Subjects With Advanced Illness and Opioid-Induced Constipation. PI: Charles von Gunten, MD. Sponsor: Wyeth Pharmaceuticals.
08-011 ED Employee Satisfaction With Shared Care Model. PI: JJ Nadicksbernd. Sponsor: SDHIPM.
09-001 ED Long Term Care Education Project, Phase II. PI: Frank Ferris, MD, Sponsor: Archstone Foundation.
09-003 ED West Grant. PI: Jessica Empeno. Sponsor: West Foundation
09-005 PS The RapID-M Study. PI: Scott Irwin, MD. Sponsor: SDHIPM
09-006 ED Automating Performance Evaluations t San Diego Hospice and The Institute for Palliative Medicine (SDHIPM). PI: Barbara Radice. Sponsor: Master’s Thesis
09-007 ED Egypt Education Intervention 2009. PI: Frank Ferris, MD. Sponsor: SDHIPM
09-008 MR Retrospective Chart Review of Hospice Patient’s Priorities and Concerns. PI: Scott Irwin, MD. Sponsor: SDHIPM
09-009 ED California Palliative Care Telephone Consultation Service. PI: Helen McNeal. Sponsor: SDHIPM
09-010 ED Slovenia Education Intervention 2009. PI: Frank Ferris, MD. Sponsor: SDHIPM
09-011 PS Mapping End-of-Life Experiences: Reconsidering the Contributions by the Dying in Palliative and Hospice Care. PI: Bruce Arnold, PhD. Sponsor: SDHIPM
09-012 MI Diagnostic Testing of Cancer Patient Blood. PI: Charles von Gunten, MD. Sponsor: Biocept, Inc.
09-013 ED Archetypal Imagery Among Hospice Workers During Encounters With Death: A Hermeneutic Case Study. PI: Isabelle DeArmond. Sponsor: PhD Dissertation-Saybrook Graduate School.
09-014 MR Retrospective Chart Review of Patients Diagnosed With a Psychiatric Disorder in a Hospice Setting. PI: Scott Irwin, MD. Sponsor: SDHIPM

Closed Studies

2009
IRB # Code Study Title/PI
09-002 ED Advanced Clinician Program. PI: Michelle Goldbach, BSN, MHA. Sponsor: SDHIPM
2008
IRB # Code Study Title/PI
08-002 PS Support by Telephone for Caregivers in Hospice (Support Tech). PI: Kristin, Kilbourn, PhD, MPH. Sponsor: University of Colorado
2007
IRB # Code Study Title
07-001 ED Goals of Care For The Younger Breast Patient – A Joint Project Between San Diego Hospice & Palliative Care and the UCSD Moores Comprehensive Cancer Center. PI: Wayne Bardwell, PhD. Sponsor: UCSD
07-002 PS Prevalence of Depression and Delirium and the Impact of Screening on Their Recognition in a Large-Scale Hospice and Palliative Care Setting. PI: Scott Irwin, MD. Sponsor: SDHIPM
07-004 MR Clinical Experience with Human Recombinant Hyaluronidase (Hylenex). PI: Charles von Gunten, MD. Sponsor: SDHIPM
07-007 MI A Prospective Uncontrolled Study of Parenteral Lidocaines Ability to Acutely Relieve Opioid-Resistant Pain. PI: Jay Thomas, MD. Sponsor: SDHIPM
07-008 MI A Prospective Pilot Study on the Prevalence of QTc Prolongation in Hospice/Palliative Medicine Patients on Methadone for Pain. PI: Anh Nguyen, MD. Sponsor: SDHIPM
2006  
IRB # Code Study Title
06-001 MI A Double-Blind, Placebo Controlled, Multicenter Phase IIB Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects. PI: Renee Smilde, MD. Sponsor: GlaxoSmithKline.
06-002 MI Pain Assessment, Incidence, and Nature in Heart Failure. PI: Jay Thomas, MD. Sponsor: PC-HEART
06-003 ED Correlation of Opioid Doses with Blood Concentrations: Morphine Sulfate. PI: Charles von Gunten, MD. Sponsor: SDHIPM
06-006 MI A Double-Blind, Placebo Controlled Evaluation of the Efficacy, Safety, and Tolerability of BEMA ™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects: Jay Thomas, MD. Sponsor: BioDelivery Sciences International, Inc.
06-008 MI An Open-Label, Long-Term Treatment Evaluation of the Safety of BEMA ™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy. PI: Jay Thomas, MD. Sponsor: BioDelivery Sciences International, Inc.
2005  
IRB # Code Study Title
05-002 MI A Randomized, Placebo Controlled Phase II Study of Parenteral Lidocaine Ability to Acutely Relieve Opioid Refractory Pain. PI: Jay Thomas, MD. Sponsor: SDHIPM
05-004 SD A Study to Validate the Content of the Functional “Assessment of Chronic Illness Therapy-Ascites Index (FACIT-AI) in Patients With Recurrent Symptomatic Malignant Ascites due to Ovarian Cancer. PI: Jay Thomas, MD. Sponsor: Fresenius Biotech
05-005 SD Values Assessment: Hospice and Child Welfare Social Workers. PI: Andra Kariiti. Sponsor: Master’s Thesis-California State University, Long Beach
05-008 MI A Randomized, Double-Blind, Placebo Controlled, Multicenter Phase IIB Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects. PI: Renee Smilde. MD. Sponsor: GlaxoSmithKline.
05-010 MI Patients and Technology in Hospice. PI: Jean S. Kutner, MD, MSPH. Sponsor: Population-Based Palliative Care Research Network.
05-011 MR Investigation of The Currently Identified Prevalence of Depression in Patients Enrolled in Hospice Care at San Diego Hospice& Palliative Care (SDHPC) During 2005. PI: Scott Irwin, MD. Sponsor: SDHIPM
05-015 MI Increased Flow Using Subcutaneously Enhanced Morphine (INFUSE-Morphine) Study: A Phase IIIB, Double-Blind, Randomized, Crossover Study Comparing the Pharmacokinetics, Safety, and Tolerability of Morphine Administered Subcutaneously With and Without Human Recombinant Hyaluronidase (HYENEX) and Intravenously. PI: Jay Thomas, MD. Sponsor: Halozyme Therapeutics, Inc.
05-016 BR An Exploration of Culture in Memorial Making with the Bereaved. PI: Noreen Carrington, LMFT. Sponsor: SDHIPM
05-018 ED Qualitative Evaluation of the Personal Project Component of the Evaluation Plan for the Existing Third-year Medical Student Curriculum. PI: Charles von Gunten, MD. Sponsor: SDHIPM
05-019 SD Practical Depression and Delirium Screening for Inpatients (ICC) at San Diego Hospice & Palliative Care (SDHPC): A Pilot Study. PI: Scott Irwin, MD. Sponsor: SDHIPM
05-021 ED Palliative Care Culture and The First Class of Nurses Interns. PI: Ann Sturley, DrPH. Sponsor: SDHIPM
05-022 BR The Effect of Dream Interpretation Intervention on Grief in Bereaved Individuals. PI: Rochelle Perper, MA. Sponsor PhD Dissertation, Alliant International University
2004  
IRB # Code Study Title
04-001 PS Patient and Caregiver Well-Being. PI: Kathryn Herbst. Sponsor: PhD Dissertation
04-007 MI Correlation Between Myoclonus and the 3-Glucuronide Meabolites in Patients on Morphone or Hydromorphone: A Pilot Study. PI: Shawn McCann, MD. Sponsor: SDHIPM
04-009 SD Consensus Working Group for Nutritional Supplements Guidelines in Palliative Care: A Performance Improvement Project for SDHPC. PI: Sharon O-Mary, MSN. Sponsor: SDHIPM
04-018 MI A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of OraVescent Fentanyl Citrate in Opioid-Tolerant Patients with Cancer and Breakthrough Pain. PI: Laurel Herbst, MD. Sponsor: Cephalon, Inc.
04-019 MI A Multicenter, Open-Label, Long-Term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid-Tolerant Cancer Patients. PI: Laurel Herbst, MD. Sponsor: Cephalon, Inc.
2003  
IRB # Code Study Title
03-002 MR Retrospective Assessment of Selected NHPCO/CMMS Guidelines for Hospice Care. PI: Laurel Herbst, MD. Sponsor: SDHIPM
03-003 MI A Three-month Open-Label Treatment Extension of Protocol MNTX 301 (MNTX 301 EXT). PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc
03-004 ED Palliative Care Curriculum for 3rd Year Medical Students. PI: Charles von Gunten, MD. Sponsor: SDHIPM
03-005 CM Reducing End-of-Life Symptoms with Touch (REST). PI: Jean Kutner, MD. Sponsor: Population-Based Palliative Care Research Network
03-006 CM The Use of Music Therapy to Decrease Agitation in Dementia Patients Receiving Hospice Homecare Services. PI: Barbara Reuer. Sponsor: MusicWorx
03-008 MI Analgesic Efficacy of Smoke Cannabis in Refractory Cancer Pain. PI: Mark Wallace, MD. Sponsor: UCSD
03-010 ED Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cancer Patients. PI: Roger Strong, NP. Sponsor: PhD Dissertation
03-011 MI A Double Blind Phase 3, Two-week Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Constipation Due to Opioid Therapy in Advanced Medical Illness (MNTX 302). PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc.
03-012 MI A Three-Month Open-Label Treatment Extension of Protocol MNTX 302. PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc.
03-014 MR A Retrospective Evaluation of a Simplified Methadone Dosing Protocol. PI: Loren Friendman, MD. Sponsor: The Hospice of the National Capital Region.
2002  
IRB # Code Study Title
02-002 MI A Comparison of Four Pain Intensity Scales Using Hospice Patients with Cancer Pain. PI: Terri Gibbs, RN. Sponsor: SDHIPM
02-004 MR The Effects of Social Support on Longevity and Quality of Life of Hospice Patients. PI: Kathryn Herbst. Sponsor: UCSD
02-005 MI A Phase II Double-Blind, Randomized, Parallel Group, Dose Ranging Study of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Bowel Dysfunction (MNTX 251). PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc.
02-007 MI Communication and Quality of Care for Terminal Cancer. PI: Wayne Beach, Ph.D. Sponsor: UCSD.
02-010 SD A Description of Home Nursing Interventions Provided to People with HIV/AIDS. PI: Linda Robinson, PhD. Sponsor: USD Hahn School of Nursing.
02-014 SD Monitoring Informed Consent for Hospice Enrollment. PI: David J. Casarett, ME. Sponsor: University of Pennsylvania
02-015 MI A Compassionate Use Study of Methylnaltrexone inpatients with Opioid-Induced Side Effects (MNTX 901). PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc
02-016 SD Phase III - National Hospice Outcomes Project. ISIS / National Hospice and Palliative Care Organization & Institute for Clinical Outcomes Research. PI: Deborah Dunne, MSN, MBA. Sponsor: SDHIPM
02-017 ED Relaxation Training and the Improvement of Quality of Life of Hospice Patients. PI: Carrie Nelson-Vasquez, MD. Sponsor: UCSD
02-018 SD Medication Prescribing Patterns by Hospice Medical Directors Study. PI: Jean S. Kutner, MD, MSPH. Sponsor: Population-Based Palliative Care Research Network
02-019 MI A Double-Blind Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Symptomatic Constipation due to Chronic Opioid Therapy in Patients with Advanced Medical Illness (MNTX 301). PI: Jay Thomas, MD. Sponsor: Progenics Pharmaceuticals, Inc.  
2001  
IRB # Code Study Title
01-001 MR Chart Review of Parenteral Lidocaine for the Management of Intractable Pain. PI: Charles von Gunten, MD & Gil Naco, MD. Sponsor: SDHIPM
01-002 CM Feasibility Study of Acupuncture in Cancer Home Care. PI: Ana de Vedia, L.Ac. Sponsor: Pacific College of Oriental Medicine
01-007 MI Helping Patients and Their Families Make Decisions About Hospice Enrollment. PI: Noreen Carrington. Sponsor: SDHIPM and University of Pennsylvania
01-008 MI Values of Patients with CHF Enrolling in Palliative Care. PI: Paul E. Tatum, MD. Sponsor: University of Missouri Columbia.
2000  
IRB #   Study Title
00-001 CM Assessment of Therapeutic Touch as a Method for Reduction of Nociceptive and Neuropathic Pain Due to Cancer Compared to Placebo and No Treatment in Terminal Phase Patients Enrolled in San Diego Hospice. PI: Irene H. Fu, MSIV, Independent Study Project. Sponsor: UCSD.
00-002 ED The San Diego Hospice Experience - A Handbook for Children About What to Expect From Hospice. PI: Jeanette Galicinao, MSIV, Independent Study Project. Sponsor: UCSD.
00-003 PS Psychosocial and Spiritual Symptoms among Hospice Patients. PI: Jean S. Kutner, MD, MSPH. Sponsor: Population-Based Palliative Care Research Network.
00-004 MI A Randomized, Double-Blind, Two-Period Crossover Trial Comparing the Safety and Effectiveness of Numorphan CR (oxymorphone controlled-release tablets) and MS Contin (morphine sulfate controlled-release tablets) for the Relief of Moderate to Severe Pain in Patients with Cancer (#EN3202-018). PI: Laurel Herbst, MD. Sponsor: Endo Pharmaceuticals, Inc. 
00-005 MI An Open-Label Assessment of the Long-Term Safety and Utility of Numorphan CR for the Relief of Moderate to Severe Pain in Patients with Cancer (#EN3202-022). PI: Laurel Herbst, MD. Sponsor: Endo Pharmaceuticals, Inc. 
00-006 MR The Effects of Social Support on Longevity and Quality of Life of Hospice Patients. Kathryn Herbst, PhD. Sponsor: UCSD
00-007 PS Hospice Discharge Follow-up Study. PI: Jean S. Kutner, MD, MSPH. Sponsor: Population-Based Palliative Care Research Network.
00-008 MR Terminal Agitation: It's Prevalence, Causes, and the Effectiveness of Interventions in the Hospice Setting. PI: Tania Mieke, MSII. Sponsor: SDHIPM
00-009 MI A Study to Assess the Safety, Dose Conversion and Titration of Duragesic (Fentanyl Transdermal System) in Pediatric Patients with Chronic Pain Requiring Opioid Therapy FEN-USA-87. PI: Alexander Rodarte. Sponsor: Janssen Research Foundation
00-011 MI Proposal to Commence Clinical Trials to Test a New Palliative Drug - Hyperbaric Oxygen - Against Obligatory Enveloped Viruses: HIV, CMV, HSV, HCV. PI: Mark A. Baugh, PharmD
1999
IRB # Code Study Title
99-001 MI The Effectiveness of Traditional Chinese Medicine on the Quality of Life of Terminally Ill Patients at San Diego Hospice. PI: Ana de Vedia, Chad Conner & Jill Blakeway. Sponsor: Pacific College of Oriental Medicine.
99-002 PS Hospice in Nursing Homes: An Empirical Examination of its Scope and Quality Outcomes. PI: Susan C. Miller, PhD. Sponsor: Brown University
1998
IRB # Code Study Title
98-001 MI Study of the Prevalence and Treatment of Breakthrough Pain in Patients Using Transdermally Delivered Fentanyl (Duragesic) for Management of Chronic Pain (C-98-034-00). PI: Laurel Herbst, MD. Sponsor: Alza Corporation
98-002 MI Open-Label Dose-Titration Study of E-TRANS (fentanyl) for the Treatment of Breakthrough Pain in Patients with Chronic Pain (C-98-035-00). PI: Laurel Herbst, MD. Sponsor: Alza Corporation
98-003 PS Effects of Communication About Terminal Illness on Marital Satisfaction and Quality of Life (Survey for patient and spouse). PI: Laura Holcomb, Clinical Psychology Ph.D. Candidate. Sponsor: University of Tennessee, Knoxville, TN
1997  
IRB # Code Study Title
97-001 MI An Open-label Trial to Assess the Efficacy of KADIAN (Morphine Sulfate Sustained Release) Using a 'Sprinkling' Method of Dose Administration in a Hospice Setting for Subjects with Chronic Moderate-to-Severe Pain. (3394US/0004) PI: Laurel Herbst, MD. Sponsor: Zeneca Pharmaceutical Company
97-002 MI A pilot trial of once-daily oral RO93877 capsules vs. placebo in opioid-induced constipation in cancer patients. (RO93877-USA-8) PI: Laurel Herbst, MD. Sponsor: Janssen Research Foundation
97-003 PS Sequenced versus Unsequenced Emotional Expression of the Conjugal Bereavement Experience. PI: Leslie Wilson, M.A. Sponsor: SDHIPM.
1996  
IRB # Code Study Title
96-001 MI Pilot Study of Three On-Demand Dose Levels of Fentanyl Delivered Intravenously by a PCA Device for the Management of Breakthrough Pain in Patients with Chronic Pain (C-95-023). Sponsor: Alza Pharmaceutical Co.
96-002 MI A Randomized, Open-Label, Cross-Over Trial to Compare the Efficacy, Subject Preference, and Safety of Kadian (morphine sulfate sustained release) Capsules vs. MS Contin (Purdue Frederick) in the Management of Subjects with Chronic Moderate to Severe Cancer Pain (3394US/0002). Sponsor: Zeneca Pharmaceutical Co.
96-003 PS Attitudes of Social Work Students and Social Workers Toward Euthanasia and Life Sustaining Treatment. PI: Ursula Leszczynska, MSW. Sponsor: Thesis
96-004 MI An Open-Label Evaluation of the Safety and Local Tolerance of Continuous Subcutaneous Infusion of Dilaudid (20 and 50 mg/ml). PI: Laurel Herbst, MD. Sponsor: Knoll Pharmaceutical
1995
IRB # Code Study Title
95-001 PS An Evaluation of Quality of Life and Treatment Satisfaction in Cancer Patients Receiving Duragesic, MS Contin or Oramorph. Sponsor: Technology Assessment Group (TAG)
95-002 MI Randomized, Single Blind Crossover Comparison Between Nebulized and Subcutaneous Morphine in the Treatment of Dyspnea in Terminal Patients. Clint Pearson, MSIV Student, Independent Study Project. Sponsor: UCSD.
95-003 MI Oral Transmucosal Fentanyl Citrate Titration and Effectiveness Study (Protocol AC 200/013) PI: Laurel Herbst, MD. Sponsor: Anesta Corp
95-004 MI Oral Transmucosal Fentanyl Citrate Effectiveness Study (Extension Protocol - AC 200/014).PI: Laurel Herbst, MD. Sponsor: Anesta Corp
95-005 PS Suicide Ideation Survey. PI: Deborah Lindholm. Sponsor: PhD Dissertation
95-006 PS The transition of parents who survive the death of a child from a terminal illness: a cross-cultural perspective. PI: Sherlynn Owens. Sponsor: PhD Dissertation
1993  
IRB # Code Study Title
93-018 MI Open-Label Study of Senokot-S Tablets in the Treatment of Opioid-Induced Constipation in Cancer Patients: A Multicenter Study (SK91-1102). Sponsor: Purdue Frederick Company
1992  
IRB # Code Study Title
92-015 MI Protocol for a Randomized, Controlled, Phase IV Study Comparing the Cost-Effectiveness of Duragesic and Infusional Parental Morphine in Cancer Patients Under the Care of a Home Hospice (JRD4263/0102). Sponsor: Janssen Research Foundation
92-016 MI A Three-Month Open-Label Extension of Protocol No. OC91-0402B: Controlled-Release Oxycodone Tablets (Q12H) in Patients with Chronic Cancer-Related Pain (OC91-0907B). Sponsor: Purdue Frederick Company
92-017 PS Determinates of Hospice Patients Place of Death. PI: Donna McCarthy, PhD
1991
IRB # Code Study Title
91-011 MI Open-Label Safety and Efficacy Study of Senokot-S in Treatment of Opioid-Induced Constipation (SK89-0804). Sponsor: Purdue Frederick Company
91-012 MI Controlled Release Oxycodone Tablets (Q12H) vs. Immediate Release Oxycodone Tablets (QID): Comparative Efficacy Safety and Acceptability in Patients Previously Stabilized on Strong Opioid Analgesics for Chronic Cancer-Related Pain (C91-0402B). Sponsor: Purdue Frederick Company
91-013 PS An Empirical Investigation of Death Dreams and the Psyche Among Cancer Patients. PI: Moruko Ralph-Wilkman, MA
91-014 BR Family Factors Influencing Effective Pain Management for Cancer Patients in the Pediatric Population. PI: Betty Ferrell, PhD, FAAN & Liz Sumner
1990
IRB # Code Study Title
90-002 BR Bereavement Study. PI: Kathleen Burns, PhD. Sponsor: SDHIPM.
90-003 ED Needs Assessments Regarding Skills of Nurses. PI: Peggy Sereda, RN. Sponsor: SDHIPM.
90-004 MI Accuracy of Cutaneous Oximetry in Assessing Dyspnea in a Population of Hospice Home Care Patients. PI: Laurel Herbst, MD. Sponsor: SDHIPM.
90-005 MI Utilization of the Quality of Life Closure Scale in Patients Following Palliative Treatment of Recurrent Malignant Airway Obstruction. PI: Laurel Herbst, MD & Elaine Fox, LCSW. Sponsor: SDHIPM
90-006 MI 9A Cross-Sectional Study to Test the Reliability and Validity of a Severity Index Designed as an Indicator of Acuity. PI: Lawrence Piro, MD & Laurel Herbst, MD
90-007 MI Alzheimer's Study. PI: Richard Katzman, MD
90-008 PS The Role of Hardiness, Job Stressors and Co-dependency on Burnout Among a Population of Oncology Nurses. PI: Elaine Fox, LCSW, Pare Ware, LCSW, Mary Callaghan, RN, & Molly Drummond, LCSW
90-009 PS Factors Affecting the Place of Death of Hospice Patients. PI: Donna McCarthy, PhD
90-010 ED Nurse's Knowledge and Attitudes about Patient Controlled Analgesic (PCA). PI: Leslie Clark, RN, MSN. Sponsor: SDHIPM
1989
IRB # Code Study Title
89-001 ED Interactive Compact Disc Simulation in Cancer Pain Management. PI: Richard Currier, MD. Sponsor: SDHIPM.

BACK TO TOP